Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gervais, CA

Andre Gervais, Quebec CA

Patent application numberDescriptionPublished
20100173339PLATELET ACTIVATION MARKERS AS INDICATORS FOR ANTI-PLATELET THERAPY - Methods for determining the appropriateness of anti-platelet therapy in a patient with a platelet-affected disease. The Mean Platelet Component value in a patient blood sample is determined corresponding to the patient's platelet activation status. A high platelet activation status indicates the appropriateness of anti-platelet therapy.07-08-2010

Andre Gervais, North Hatley CA

Patent application numberDescriptionPublished
20080311606Platelet Activation Markers and Predictors of Desease and of Response to Therapy and for Monitoring Therapeutic Progress - Methods for assessing patient risk for platelet-affected disease states are disclosed. Also disclosed are methods for predicting the appropriateness of platelet antagonist therapy, and for monitoring patients during therapeutic intervention or during a combined regimen of therapy and angioplasty.12-18-2008

Douglas Damasse Gervais, Ottawa CA

Patent application numberDescriptionPublished
20110115173Baby Evacuation Device - The invention provides an evacuation device for one operator, with a plurality of babies secured in pockets, having their heads secured in adjustable cushioned head rests which are attached to a patient support membrane, to descend a stairwell safely and quickly during an emergency. The invention is constructed of a tubular frame, covered with a fire-retardant, water impermeable and mold and fungus resistant material. The invention incorporates a set of casters for transport across a horizontal plane, such as crowded hallways and small hospital stairwell landings. The dual track system permits the operator to glide down the stairs in a safe, smooth and controlled fashion. The dual braking device on the track system assists the operator in a stairwell descent and permits the operator to release the chair and remove any debris that may be in the path of evacuation.05-19-2011

Éric Gervais, Laval CA

Patent application numberDescriptionPublished
20110059026PHARMACEUTICAL DOSAGE FORM BEARING PREGNANCY-FRIENDLY INDICIA - A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to improve patient compliance with medically recommended dosage regimen resulting in improved product effectiveness. The pregnancy-friendly indicia is also apt to diminish the incidence of erroneous dispensing of or erroneous ingestion of pharmaceutical dosage forms not intended for pregnant women. Also disclosed is a method for achieving improved patient compliance resulting in improved product effectiveness. Also disclosed is a method for diminishing the incidence of erroneous dispensing of or erroneous ingestion of dosage forms not intended for pregnant women. Said methods comprising providing a pharmaceutical dosage form, intended for use by pregnant women, bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.03-10-2011
20110305642MICRONUTRIENT SUPPLEMENT - A micronutrient supplement the supplement being characterized by having at least two types of distinct dosage units wherein said distinct dosage units which physically separate nutritional, vitamin or mineral supplements which are known or proven to be negatively interacting when co-mingled or co-administered, the distinct dosage units being designed to be taken at a predetermined time interval.12-15-2011
20110305775Micronutrient Supplement Dispensing Package - Provided herein is a prenatal and postpartum multivitamin and mineral supplement package provided in the form of a plurality of solid oral dosage units individually contained in blister packs wherein a portion of the dosage forms are iron-containing while at least half of the dosage units are essentially iron-free and wherein the total amount of iron in the package as sold to purchasers is less than about 1300 mg of elemental iron.12-15-2011

Éric Gervais, Laval CA

Patent application numberDescriptionPublished
20110059026PHARMACEUTICAL DOSAGE FORM BEARING PREGNANCY-FRIENDLY INDICIA - A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to improve patient compliance with medically recommended dosage regimen resulting in improved product effectiveness. The pregnancy-friendly indicia is also apt to diminish the incidence of erroneous dispensing of or erroneous ingestion of pharmaceutical dosage forms not intended for pregnant women. Also disclosed is a method for achieving improved patient compliance resulting in improved product effectiveness. Also disclosed is a method for diminishing the incidence of erroneous dispensing of or erroneous ingestion of dosage forms not intended for pregnant women. Said methods comprising providing a pharmaceutical dosage form, intended for use by pregnant women, bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.03-10-2011

Patent applications by Éric Gervais, Laval CA

Francine Gervais, Iie Bizard CA

Patent application numberDescriptionPublished
20080317834Compounds and methods for modulating cerebral amyloid angiopathy - The invention provides methods of inhibiting cerebral amyloid angiopathy. The invention further provides methods of treating a disease state characterized by cerebral amyloid angiopathy in a subject.12-25-2008

Francine Gervais, Ile Bizard CA

Patent application numberDescriptionPublished
20080249184Methods for modulating neuronal cell death - The invention provides methods of inhibiting Aβ-induced neuronal cell death. The invention further provides methods of providing neuroprotection to a subject and methods of treating a disease state characterized by Aβ-induced neuronal cell death in a subject. Methods of inhibiting p75 receptor mediated neuronal cell death, as well as methods of treating a disease state in a subject characterized by p75 receptor mediated neuronal cell death are provided.10-09-2008
20100113591METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES - Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.05-06-2010
20100190753Methods and Compositions for Treating Amyloid-Related Diseases - Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-+related disease.07-29-2010
20120015911METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES - Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.01-19-2012

Patent applications by Francine Gervais, Ile Bizard CA

Francois Gervais, Laval CA

Patent application numberDescriptionPublished
20080238438WIRELESS PORTABLE AUTOMATED HARNESS SCANNER SYSTEM AND METHOD THEREFOR - The present document describes a system for offline testing of an installed wiring harness, comprising: at least a first and a second testing module, having: a communication module for receiving test specifications and for sending test measurements; testing equipment for generating the test measurements from the test specifications; each of the first and second testing modules being adapted for connection at a connection point in the wiring harness; a central network management module, having: a communication module for providing the test specifications to the testing modules and for receiving the test measurements; and a test management module for controlling the testing modules.10-02-2008
20100073007WIRELESS PORTABLE AUTOMATED HARNESS SCANNER SYSTEM AND METHOD THEREFOR - The present document describes an assembly for interfacing an existing harness connector of an installed wiring harness to a test module, the assembly comprising: a harness-specific connector for connecting to the existing harness connector; a test box connector module connected to the harness-specific connector and for connecting to a test module, the test box connector module comprising a key which is unique to the test box connector module and which is used to identify the test box connector module when connected to the test module. There is described a method for identifying a test box connector module used in testing an installed wiring harness comprising an existing harness connector, the method comprising: connecting the test box connector module to a test module; detecting a key which is unique to the test box connector module thereby determining the identity of the test box connector module; sending the identity of the test box connector module to a user interface.03-25-2010

Patent applications by Francois Gervais, Laval CA

Francois Gervais, Kirkland CA

Patent application numberDescriptionPublished
20110160070COPD BIOMARKER SIGNATURES - The present invention relates to methods of detecting differentially expressed protein expression indicative of COPD in a test sample. The detection of circulating levels of proteins within an identified COPD biomarker signature can aid in COPD diagnosis and disease monitoring, as well as in the prediction of responses to therapeutics. Evaluation of the biomarker signatures disclosed, or a subset of biomarkers thereof, provides a level of discrimination not found with individual markers.06-30-2011

Joel Gervais, Saskatoon CA

Patent application numberDescriptionPublished
20110056308System and Method for Measuring Flow Rate From a Meter Roller - A system and method are provided for quantifying a degree of discontinuity of material flow from a meter roller. In an exemplary embodiment, flowable particulate material is fed into a meter roller. The meter roller is then rotated one revolution, and the output from the meter roller is collected and measured. Next, the meter roller is rotated one revolution in discrete increments, each increment having a substantially equal rotational angle. The output from the meter roller is then collected and measured for each increment. Finally, the measurement for each increment is compared to the measurement for the one revolution to determine a statistical parameter indicative of flow rate discontinuity.03-10-2011

Joseph Lucien Fernand Gervais, Manitouwadge CA

Patent application numberDescriptionPublished
20120018558Rock crusher attachment - The present invention relates to the field of rock crushers, in particular, rock crusher attachments for earth moving equipment or the like. The rock crusher attachment includes a front bucket portion configured for scooping rocks to be crushed and a rear crusher portion connected to and in communication with the rear of the bucket portion. The crusher portion includes a housing and a crushing assembly accommodated within the housing. The housing including a pair of spaced apart side panels. The crushing assembly has a lower jaw fixed between the side panels of the housing and an upper movable jaw mounted opposite and spaced apart from the lower jaw. The upper movable jaw assembly includes a support, an upper jaw plate attached to the underside of the support and a jaw-actuating drive assembly operable to urge the upper movable jaw assembly to move between an open jaw setting and a closed jaw setting. The support is pivotally connected between the side panels adjacent the front of the housing. The jaw-actuating drive assembly includes at least one motor carried by the support. The at least one motor is urged to move along with the upper movable jaw assembly relative to the lower jaw, when the crusher assembly is actuated.01-26-2012

Stephen Gervais, Collingwood CA

Patent application numberDescriptionPublished
20100098871SPRAY COATING SYSTEM AND METHOD - The present invention is directed to a robotic spray coating assembly and method for spraying a coating. The assembly may include a robotic arm having a remote end region and a coating head mounted on the remote end region. The coating head emits a coating material within a defined coating delivery region via at least one first orifice located in the coating delivery region, the at least one first orifice connected to a coating supply. One or more second orifices are positioned in a pattern beyond the periphery of the coating delivery region, and a fluid supply is connected to the one or more second orifices. Fluid emitted from the one or more second orifices forms a fluid curtain that at least partially encircles the coating delivery region, thereby minimizing overspray emerging therefrom. The present invention also discloses a vehicle spray painting system and a method of spray painting a vehicle.04-22-2010